Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Preferred Stock Liabilities (2024 - 2025)

Carlsmed (CARL) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $29.8 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Preferred Stock Liabilities rose 119.48% year-over-year to $29.8 million, compared with a TTM value of $29.8 million through Jun 2025, up 119.48%, and an annual FY2024 reading of $29.8 million, changed N/A over the prior year.
  • Preferred Stock Liabilities was $29.8 million for Q2 2025 at Carlsmed, roughly flat from $29.8 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $52.8 million in Q3 2024 and bottomed at $13.6 million in Q2 2024.